Werneburg et al. (2020) induced AAV9-mediated expression of the C3 inhibitor Crry in both eyes of a mouse model of MS and reported that this practice inhibited microglial phagocytosis in synapses of the LGN, thereby restoring visual function. The gene discussed is C3; the disease is myeloid sarcoma.